Drugs / PRP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02607462 | Nov 2015 → Oct 2017 | osteoarthritis, hip | Satakunta Central Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02607462 ↗ |
| Modality | Protein / enzyme biologic | “PRP is a concentrate of platelet-rich plasma proteins derived from whole blood by centrifugation to remove erythrocytes and leukocytes.” PMID 29923073 ↗ Jun 2018 |
| Route | Intramuscular | “Single Injection of Platelet-rich Plasma (PRP) to m. Gluteus Medius During Total Hip Arthroplasty Using Direct Lateral (Hardinge) Approach” NCT02607462 ↗ |